Advertisement
Canada markets open in 7 hours 31 minutes
  • S&P/TSX

    22,824.67
    +45.10 (+0.20%)
     
  • S&P 500

    5,436.44
    -27.10 (-0.50%)
     
  • DOW

    40,743.33
    +203.40 (+0.50%)
     
  • CAD/USD

    0.7225
    +0.0004 (+0.05%)
     
  • CRUDE OIL

    76.14
    +1.41 (+1.89%)
     
  • Bitcoin CAD

    91,470.52
    -576.52 (-0.63%)
     
  • CMC Crypto 200

    983.43
    -387.05 (-22.37%)
     
  • GOLD FUTURES

    2,462.60
    +10.70 (+0.44%)
     
  • RUSSELL 2000

    2,243.14
    +7.81 (+0.35%)
     
  • 10-Yr Bond

    4.1430
    -0.0350 (-0.84%)
     
  • NASDAQ futures

    19,208.25
    +272.00 (+1.44%)
     
  • VOLATILITY

    17.69
    +1.09 (+6.57%)
     
  • FTSE

    8,274.41
    -17.94 (-0.22%)
     
  • NIKKEI 225

    38,757.43
    +231.48 (+0.60%)
     
  • CAD/EUR

    0.6671
    -0.0004 (-0.06%)
     

Johnson & Johnson (NYSE:JNJ) is largely controlled by institutional shareholders who own 71% of the company

Key Insights

  • Given the large stake in the stock by institutions, Johnson & Johnson's stock price might be vulnerable to their trading decisions

  • A total of 25 investors have a majority stake in the company with 42% ownership

  • Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock

Every investor in Johnson & Johnson (NYSE:JNJ) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 71% to be precise, is institutions. Put another way, the group faces the maximum upside potential (or downside risk).

Since institutional have access to huge amounts of capital, their market moves tend to receive a lot of scrutiny by retail or individual investors. Therefore, a good portion of institutional money invested in the company is usually a huge vote of confidence on its future.

ADVERTISEMENT

Let's take a closer look to see what the different types of shareholders can tell us about Johnson & Johnson.

Check out our latest analysis for Johnson & Johnson

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Johnson & Johnson?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

As you can see, institutional investors have a fair amount of stake in Johnson & Johnson. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Johnson & Johnson, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth
earnings-and-revenue-growth

Institutional investors own over 50% of the company, so together than can probably strongly influence board decisions. Hedge funds don't have many shares in Johnson & Johnson. The company's largest shareholder is The Vanguard Group, Inc., with ownership of 9.5%. With 7.9% and 5.5% of the shares outstanding respectively, BlackRock, Inc. and State Street Global Advisors, Inc. are the second and third largest shareholders.

On studying our ownership data, we found that 25 of the top shareholders collectively own less than 50% of the share register, implying that no single individual has a majority interest.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

Insider Ownership Of Johnson & Johnson

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

Our most recent data indicates that insiders own less than 1% of Johnson & Johnson. It is a very large company, so it would be surprising to see insiders own a large proportion of the company. Though their holding amounts to less than 1%, we can see that board members collectively own US$267m worth of shares (at current prices). Arguably recent buying and selling is just as important to consider. You can click here to see if insiders have been buying or selling.

General Public Ownership

The general public, who are usually individual investors, hold a 29% stake in Johnson & Johnson. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Next Steps:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. To that end, you should learn about the 2 warning signs we've spotted with Johnson & Johnson (including 1 which is concerning) .

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com